進化する核医学治療:標的アルファ線治療法の開発

長谷川純崇 · Institutional Repositories DataBase (IRDB) · 2022

Alpha-particle radiation, a type of particle radiation, is highly cytotoxic because it deposits a large amount of energy within a few cell diameters (50-100 micrometers). It induces irreparable DNA damages including DNA double strand break to kill the target cell or tissue. Targeted delivery of alpha-particle radiation into cancer cells allows us to ablate cancer cells with sparing the surrounding normal tissues. Targeted alpha-therapy (TAT) therefore attracts much attention as an emerging therapy against cancer. Recently, we have successfully developed several antibodies armed with astatine-211, a promising alpha-emitter radionuclide, to provide a proof-of-concept demonstration that TAT may offer a new therapeutic option for cancers, especially conventional therapy-resistant cancers. In this workshop, we will share our recent progress on experimental TAT to discuss the future of TAT as an option for cancer therapy.

Cited by 0 works.

Authors